Subscribe to our Newsletters !!

    Kumar Jeetendra

    Secret genetic defects can prompt a wide range of serious illnesses

    For the first time researchers from Hebrew University of Jerusalem, Radboudumc, Maastricht UMC+ and worldwide colleagues have gained insight to the”hidden genetic defects” of the general European population. This is important as these defects, if inherited from the father and mother, can result in all kinds of disorders in their children. Research in the Dutch

    VR offers desire to nerve injury patients encountering chronic pain

    We all feel physical pain in various ways, but people with nerve injuries frequently have a dysfunctional pain reduction system, making them particularly prone to distress. Now researchers have found that virtual reality (VR) can reduce types of pain typically found in patients with nerve injuries – which VR can raise the dysfunctional pain suppression

    Roche and GenMark Diagnostics signs Definitive Merger Agreement

    Roche, Basel, Switzerland, and GenMark Diagnostics, Carlsbad, Calif, have entered into a definitive merger agreement for Roche to completely acquire GenMark at a price of $24.05 per share in an all-cash trade. This corresponds to a total transaction value of approximately $1.8 billion on a fully diluted basis. The merger agreement has been unanimously approved

    FDA approves first AI based COVID-19 non-diagnostic screening

    Now, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first machine learning-based Coronavirus Disease 2019 (COVID-19) non-diagnostic testing apparatus that identifies certain biomarkers that are indicative of some kinds of conditions, such as hypercoagulation (a condition causing blood to clot more readily than normal). The Tiger Tech COVID Plus

    Intense openness of lung tissue to vape airborne lesserly affects gene expressionthan cigarette smoke

    A new peer-reviewed study published in the journal Toxicological Research & Application reveals acute exposure of a 3D human bronchial tissue model to e-cigarette aerosol has minimal impact on gene expression in contrast to smoke from combustible cigarettes. The study included sub-cytotoxic vulnerability to cells in a 3D human bronchial model (MucilAirTM) to nicotine-containing vape

    Ultra-Absorptive Nanofiber Swabs developed by Researchers

    Ultra-absorptive nanofiber swabs developed by researchers at the University of Nebraska Medical Center could reduce the number of false-negative tests for covid-19 by improving sample collection and test sensitivity.1 Reverse transcriptase-polymerase chain reaction (RT-PCR) tests to discover SARS-CoV-2 RNA frequently need a long swab to collect a specimen from deep within a patient’s nasal cavity.

    Bacteria residing within inside tumor cells can support malignant growth immunotherapy

    Cancer immunotherapy may get a boost from an unexpected direction: bacteria residing within tumor cells. The study may also help clarify the connection between immunotherapy and the intestine microbiome, describing the findings of earlier research that the microbiome impacts the success of immunotherapy. Immunotherapy remedies of the last decade or so have dramatically improved healing

    Presenting Inhalytix™: Solution for analysing and managing inhaler test data from Copley

    Inhalytix™ is a completely new software solution from Copley, the global leader in inhaler testing equipment, that brings a standardized approach to cascade impactor data analysis, efficiently converting raw data into performance-defining metrics for all inhaled products. Cascade impactors determine aerodynamic particle size distribution (APSD), a critical quality attribute for inhaled drug delivery. Inhalytix™ is

    Universal microplastics can become ‘centers’ for antibiotic-resistant bacteria

    It is estimated that an average-sized wastewater treatment plant serving approximately 400,000 inhabitants will discharge up to 2,000,000 microplastic particles to the environment every day. Yet, researchers are still learning the ecological and human health impact of these ultra-fine plastic particles, less than 5 millimeters in length, found in everything from makeup, toothpaste and clothes

    Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats

    March 23, 2021, MUMBAI – Cipla Therapeutics, an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as “Cipla”) and SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market announced entering into a strategic partnership to deliver sustained innovation and access to novel antibacterial drugs, particularly